NY A03775

Legalizes medical psilocybin use in New York when administered in clinical settings under supervision of certified facilitators, including mental health counselors, psychologists, physicians, nurses, and social workers who complete department-approved training

Establishes a naturally grown medical psilocybin pilot program through the Department of Agriculture and Markets, allowing accredited universities and colleges to participate in cultivation, treatment, and research programs

Creates a $5 million psilocybin and MDMA assisted therapy grant program to fund treatment for veterans, first responders, retired first responders, and low-income individuals

Provides legal protections for patients, practitioners, and facilitators from arrest, prosecution, civil penalties, or professional disciplinary action for certified medical psilocybin use

Establishes a 13-member Psilocybin Assisted Therapy Advisory Board appointed by the governor and legislative leaders to advise on program implementation, safety standards, and long-term strategic planning